Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance

NCT07568275 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Septic Shock
Cirrhosis
Vasodilatory Shock
Acute Kidney Injury

Interventions

DRUG: Giapreza

Sponsor

The Cleveland Clinic

Collaborators

[object Object]